Source comparison
TB-500 Lyophilized Powder: Dosing Comparison
This table compares standard TB-500 dosing protocols used in published research studies, along with reconstitution parameters and administration frequency. Acute injury model 2.0–2.5 mg 2 mL bacteriostatic water 1.0–1.25 mg/mL Twice weekly for 4 weeks Most com
This comparison does not assign a generated winner or score.
- This table compares standard TB-500 dosing protocols used in published research studies, along with reconstitution parameters and administration frequency.
- Acute injury model
- 2.0–2.5 mg
- 2 mL bacteriostatic water
- 1.0–1.25 mg/mL
- Twice weekly for 4 weeks
- Most commonly cited dosing range in rodent and equine studies. Demonstrates measurable effect on tissue repair markers
- Chronic tissue repair
- 5.0 mg
- 2.5 mL bacteriostatic water
- 2.0 mg/mL
- Once weekly for 6–8 weeks
- Higher dose used in longer-duration protocols. Requires larger peptide inventory and precise reconstitution to avoid waste
- Maintenance protocol
- 1.0–1.5 mg
- 1.5 mL bacteriostatic water
- 0.67–1.0 mg/mL
- Once every 10–14 days
- Lower dose suitable for sustained observation. Minimizes peptide consumption while maintaining detectable plasma levels
- Loading phase
- 2.5 mg
- 1.25 mg/mL
- Daily for 5–7 days, then twice weekly
- Front-loaded administration seen in some angiogenesis studies. Aims for rapid tissue saturation before transitioning to maintenance